Pmel-1 CD8 splenocytes express a transgenic TCR that recognizes gp10025-33 in the context of H-2Db; adoptive transfer of activated Pmel-1 can mediate partial or complete regression of established B16 melanoma in various animal tumor models[23,24]. Here, CD8A is linked to neoplasm.